Published in the Journal of Clinical Oncology, University of Minnesota Medical School researchers led a study that demonstrated the safety of using microbiota transplant therapy (MTT) in patients with acute myeloid leukemia ...
Jul 6, 2023
0
5
The first investigation to delve into genetic predisposition for early-onset colorectal cancer by race and ethnicity has identified differing germline risk variants.
Jun 30, 2023
0
5
A blood-based test developed by researchers at The University of Texas MD Anderson Cancer Center can efficiently predict an individual's risk of dying from lung cancer when combined with a personalized risk model.
Jun 28, 2023
0
21
An accurate tool that is readily available could be used to predict whether frail patients are likely to survive intensive cancer treatments such as chemotherapy, according to researchers from the University of Surrey.
Jun 26, 2023
0
0
Combining five existing drugs can keep a highly aggressive type of bone marrow cancer at bay for longer, an innovative trial has shown.
Jun 23, 2023
0
20
Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the lungs but also in brain metastases for patients ...
Jun 16, 2023
0
28
Results from the NRG Oncology NRG-RTOG 0232 clinical trial adding external beam radiotherapy (EBRT) to brachytherapy (BT) in men with intermediate-risk prostate cancer indicate that there was no improvement in freedom from ...
Jun 15, 2023
0
2
Oncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic hormone-sensitive prostate cancer (mHSPC).
Jun 9, 2023
0
9
The U.S. government could save taxpayers between $228 million and $2.15 billion a year if insurers who operate its Medicare Part D plans purchased seven generic oncology drugs at the same prices obtained by the Mark Cuban ...
Jun 8, 2023
0
16
The American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statement today regarding the PROSPECT clinical trial for patients with rectal cancer:
Jun 7, 2023
0
29
